Market Outlook
The global Erectile Dysfunction market size was valued at USD 5004.7 million in 2022 and is forecast to a readjusted size of USD 7899.3 million by 2029 with a CAGR of 6.7% during review period.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
Eli Lilly is one of the most important global key manufacturers of erectile dysfunction, holds a share of about 10%, other key players include Teva Pharma and Pfizer, etc. North America is the largest market, occupied for over 40 percent, followed by Europe. In terms of type, tadalafil type is the largest segment, with a share of over 50%, and in terms of sales channels, the hospital pharmacies segment holds a share of over 30 percent.
This report is a detailed and comprehensive analysis for global Erectile Dysfunction market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Erectile Dysfunction market size and forecasts, in consumption value ($ Million), sales quantity (Million Pill), and average selling prices (USD/Pill), 2018-2029
Global Erectile Dysfunction market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Million Pill), and average selling prices (USD/Pill), 2018-2029
Global Erectile Dysfunction market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Million Pill), and average selling prices (USD/Pill), 2018-2029
Global Erectile Dysfunction market shares of main players, shipments in revenue ($ Million), sales quantity (Million Pill), and ASP (USD/Pill), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Erectile Dysfunction
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Erectile Dysfunction market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
Yabang Pharmacy
Segmentation By Type
Sildenafil
Tadalafil
Others
Segmentation By Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Erectile Dysfunction Market in 2025?
The growth of the erectile dysfunction market in 2025 is driven by increasing awareness, advancements in treatment options, and growing acceptance of ED therapies. Additionally, the development of non-invasive treatments and personalized medications enhances patient compliance and overall satisfaction.
What are the weaknesses of the Erectile Dysfunction Market in 2025?
One significant weakness is the high cost of certain treatments, which may limit accessibility for a large segment of the population. There may also be a lack of awareness or stigma associated with seeking treatment, preventing many men from addressing the condition.
What opportunities exist in the Erectile Dysfunction Market in 2025?
Opportunities lie in the development of new, more affordable medications, as well as expanding telemedicine and online consultation services to increase access to treatment. Partnerships between pharmaceutical companies and healthcare providers could also lead to improved patient outcomes.
What threats does the Erectile Dysfunction Market face in 2025?
The erectile dysfunction market faces competition from alternative and natural remedies, as well as regulatory challenges. There may also be a risk of market saturation as the number of available treatments increases, which could reduce profitability for pharmaceutical companies.
Market PESTEL Analysis
What political factors will affect the Erectile Dysfunction Market in 2025?
Political stability and healthcare policies play a crucial role in shaping the erectile dysfunction market. Government regulations on the approval and pricing of ED treatments, along with the availability of healthcare coverage for such treatments, will significantly influence market access and affordability.
How will economic factors impact the Erectile Dysfunction Market in 2025?
Economic factors, including disposable income levels and healthcare spending, will directly influence the purchasing power of patients. A strong economy could lead to increased demand for ED treatments, while economic downturns may hinder affordability and reduce consumer spending on non-essential healthcare services.
What social factors are relevant to the Erectile Dysfunction Market in 2025?
Social acceptance and awareness of erectile dysfunction are growing, reducing stigma and encouraging more men to seek treatment. Changing attitudes toward men’s health and aging, along with the increasing role of telemedicine, will expand the market and make treatments more accessible.
How do technological factors affect the Erectile Dysfunction Market in 2025?
Technological advancements in telemedicine, digital health solutions, and new drug delivery systems will improve patient access to treatments. Innovative therapies, such as gene therapy and stem cell treatments, may revolutionize the market, offering new, less invasive treatment options.
What environmental factors could influence the Erectile Dysfunction Market in 2025?
Environmental factors such as the increasing focus on sustainability in healthcare products could lead to the development of eco-friendly and sustainable ED treatment options. The rise of green manufacturing practices and the reduction of environmental impact in drug production might influence consumer choices.
What legal factors should be considered in the Erectile Dysfunction Market in 2025?
Regulations around drug approval processes, patent protections, and intellectual property rights will affect market competition and innovation. Legal challenges regarding the safety and efficacy of new ED treatments could delay product launches, while increased legal scrutiny on online platforms offering ED drugs may impact distribution channels.
Market SIPOC Analysis
Who are the suppliers in the Erectile Dysfunction Market in 2025?
Suppliers in the erectile dysfunction market include pharmaceutical companies that manufacture medications like PDE5 inhibitors, medical device manufacturers producing vacuum pumps or penile implants, and technology providers offering telemedicine platforms for consultations.
Who are the inputs in the Erectile Dysfunction Market in 2025?
Inputs include raw materials for manufacturing ED treatments, such as active pharmaceutical ingredients, medical equipment, and technological infrastructure for telemedicine services. Research and development also contribute significantly as inputs for innovation in treatment options.
Who are the processes in the Erectile Dysfunction Market in 2025?
Processes in this market involve drug development, clinical trials, regulatory approvals, marketing and sales strategies, patient education and awareness, healthcare provider consultations, and post-treatment follow-up care. These steps ensure the effective delivery of ED treatments to patients.
Who are the outputs in the Erectile Dysfunction Market in 2025?
Outputs are the wide range of available treatments, including oral medications, injectable therapies, penile implants, and non-invasive options like vacuum pumps. Additionally, improved patient satisfaction and quality of life, along with increased market access, are key outputs.
Who are the customers in the Erectile Dysfunction Market in 2025?
Customers include men experiencing erectile dysfunction, healthcare providers prescribing treatments, pharmaceutical distributors, and telemedicine platforms that offer consultations and prescriptions. Additionally, insurance companies play a role by covering treatment options for eligible patients.
Market Porter's Five Forces
How does the threat of new entrants impact the Erectile Dysfunction Market in 2025?
The threat of new entrants in the erectile dysfunction market is moderate. While there is significant demand for ED treatments, the high cost of research and development, regulatory hurdles, and the established presence of large pharmaceutical companies make it difficult for new players to enter the market easily.
How does the bargaining power of suppliers affect the Erectile Dysfunction Market in 2025?
The bargaining power of suppliers is relatively low in the erectile dysfunction market. There are many suppliers of the raw materials required for manufacturing ED medications and devices, which reduces their ability to control prices or impose unfavorable terms on manufacturers.
How does the bargaining power of buyers impact the Erectile Dysfunction Market in 2025?
The bargaining power of buyers is moderate. Patients have access to a variety of treatment options, and as awareness grows, they are more informed about their choices. However, factors like cost, availability of insurance coverage, and physician recommendations still influence purchasing decisions.
How does the threat of substitute products influence the Erectile Dysfunction Market in 2025?
The threat of substitutes is high in the erectile dysfunction market. Natural remedies, lifestyle changes, and alternative therapies offer non-pharmaceutical options for patients, which could divert demand away from traditional ED treatments. These substitutes may appeal to consumers seeking more affordable or non-invasive solutions.
How does the intensity of competitive rivalry affect the Erectile Dysfunction Market in 2025?
Competitive rivalry is strong in the erectile dysfunction market. Established pharmaceutical companies and device manufacturers compete to offer the most effective and affordable treatments. New innovations, such as telemedicine and non-invasive therapies, add further competition to an already saturated market.
Market Upstream Analysis
What are the key upstream factors affecting the Erectile Dysfunction Market in 2025?
Key upstream factors include the availability and cost of raw materials used in the production of medications and medical devices, as well as the investment in research and development for new treatments. The regulatory environment also plays a significant role, as drug and device manufacturers must meet strict approval standards before products can reach the market.
How do suppliers influence the Erectile Dysfunction Market in 2025?
Suppliers of pharmaceutical ingredients, medical devices, and technological solutions for ED treatments have a direct influence on the market. Their ability to deliver high-quality materials at competitive prices impacts production costs and ultimately affects the pricing of end products. Supplier relationships are crucial for ensuring timely delivery and quality control.
How does the research and development landscape affect the Erectile Dysfunction Market in 2025?
Research and development (R&D) is critical for driving innovation in the erectile dysfunction market. Ongoing advancements in drug formulations, device technologies, and personalized treatments are shaping the future of the market. Companies investing in R&D can gain a competitive edge by offering more effective or less invasive treatments.
How do regulatory factors impact the upstream activities in the Erectile Dysfunction Market in 2025?
Regulatory factors significantly affect upstream activities in the ED market. Pharmaceutical companies and device manufacturers must navigate complex approval processes, which can delay product launches and increase costs. Stringent regulations around safety, efficacy, and marketing also influence production practices and timelines.
What role does competition play in the upstream part of the Erectile Dysfunction Market in 2025?
Intense competition among manufacturers of ED treatments drives innovation and improves product quality. This competitive pressure can lead to lower prices for consumers, but it also forces companies to continuously enhance their R&D efforts to maintain or gain market share. Competition among suppliers for raw materials can also impact costs and availability.
Market Midstream Analysis
What are the key midstream factors affecting the Erectile Dysfunction Market in 2025?
Key midstream factors include the distribution and logistics of ED treatments, as well as the role of healthcare providers in prescribing and administering treatments. The effectiveness of supply chains and the accessibility of treatments through various channels, such as pharmacies and online platforms, are also critical to market dynamics.
How does the role of healthcare providers impact the Erectile Dysfunction Market in 2025?
Healthcare providers are central to the midstream phase as they diagnose, recommend, and prescribe appropriate treatments for erectile dysfunction. Their expertise and patient relationships influence treatment adoption, and healthcare professionals are increasingly involved in educating patients about newer treatment options and non-invasive therapies.
What impact does patient access to treatments have on the Erectile Dysfunction Market in 2025?
Patient access to treatments is a key midstream concern, influenced by factors like insurance coverage, affordability, and availability through physical or online pharmacies. Increased access to telemedicine services, where patients can consult with healthcare professionals remotely, is also expanding treatment options for many individuals who previously had limited access.
How does market competition affect midstream activities in the Erectile Dysfunction Market in 2025?
Market competition in the midstream phase drives the availability and pricing of ED treatments. Pharmaceutical companies and medical device manufacturers compete to secure distribution agreements and retailer partnerships, which directly affects how widely products are accessible to consumers. Effective partnerships with healthcare providers also ensure a broader reach for new treatments.
How do marketing and promotional activities influence the midstream part of the Erectile Dysfunction Market in 2025?
Marketing and promotional activities are essential in the midstream phase as they inform both patients and healthcare providers about the latest treatments available. Effective marketing campaigns help reduce stigma and encourage more men to seek treatment. They also influence prescribing patterns and help differentiate products in a competitive market.
Market Downstream Analysis
What are the downstream impacts of the growing erectile dysfunction market?
The growing erectile dysfunction market will lead to increased demand for healthcare providers, diagnostic services, and pharmacies. Providers may need to expand their offerings, including more urology specialists and therapy options. Pharmacies will experience a rise in demand for ED-related medications and devices, creating business opportunities in the retail sector.
How will new treatment options influence downstream industries?
With the introduction of new treatments, including advanced drug formulations and devices, downstream industries such as medical device manufacturing and pharmaceutical distribution will see significant growth. Companies will need to invest in manufacturing, distribution networks, and marketing to meet the demands for these novel therapies.
What is the effect of greater awareness of ED on downstream services?
As awareness of erectile dysfunction treatments grows, downstream sectors such as patient education services, counseling centers, and telehealth platforms will experience greater demand. Health coaches and online therapy services will see a rise in their customer base, leading to expanded services in virtual care.
How will telemedicine impact downstream market segments?
Telemedicine will influence downstream market segments by driving the growth of virtual consultations and remote monitoring services. Increased reliance on digital platforms will require enhancements in IT infrastructure, digital health tools, and online pharmaceutical services, creating new market dynamics in digital healthcare solutions.
How will competition in the ED market affect downstream supply chains?
Increased competition among ED treatment providers will put pressure on downstream supply chains to offer more competitive pricing, faster delivery, and higher quality products. This could lead to more streamlined distribution channels, increased collaboration between manufacturers and retailers, and better customer service.
What are the implications of increasing demand for personalized care on downstream industries?
The demand for personalized care will impact downstream industries by creating opportunities for customized treatment solutions. This includes tailored medications, specialized devices, and personalized health plans. Medical professionals, diagnostic labs, and therapy providers will need to enhance their offerings to meet individual patient needs.
Chapter 1, to describe Erectile Dysfunction product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Erectile Dysfunction, with price, sales, revenue and global market share of Erectile Dysfunction from 2018 to 2023.
Chapter 3, the Erectile Dysfunction competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Erectile Dysfunction breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Erectile Dysfunction market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Erectile Dysfunction.
Chapter 14 and 15, to describe Erectile Dysfunction sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Erectile Dysfunction
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Erectile Dysfunction Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Sildenafil
1.3.3 Tadalafil
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Erectile Dysfunction Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Private Clinics
1.4.4 Retail Pharmacies
1.4.5 E-Commerce (B2B)
1.4.6 E-Commerce (B2C)
1.5 Global Erectile Dysfunction Market Size & Forecast
1.5.1 Global Erectile Dysfunction Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Erectile Dysfunction Sales Quantity (2018-2029)
1.5.3 Global Erectile Dysfunction Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Erectile Dysfunction Product and Services
2.1.4 Eli Lilly Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Eli Lilly Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Erectile Dysfunction Product and Services
2.2.4 Pfizer Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Erectile Dysfunction Product and Services
2.3.4 Bayer Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bayer Recent Developments/Updates
2.4 BaiYunShan General Factory
2.4.1 BaiYunShan General Factory Details
2.4.2 BaiYunShan General Factory Major Business
2.4.3 BaiYunShan General Factory Erectile Dysfunction Product and Services
2.4.4 BaiYunShan General Factory Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BaiYunShan General Factory Recent Developments/Updates
2.5 S.K. Chemicals
2.5.1 S.K. Chemicals Details
2.5.2 S.K. Chemicals Major Business
2.5.3 S.K. Chemicals Erectile Dysfunction Product and Services
2.5.4 S.K. Chemicals Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 S.K. Chemicals Recent Developments/Updates
2.6 Teva Pharma
2.6.1 Teva Pharma Details
2.6.2 Teva Pharma Major Business
2.6.3 Teva Pharma Erectile Dysfunction Product and Services
2.6.4 Teva Pharma Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Pharma Recent Developments/Updates
2.7 Dong-A ST
2.7.1 Dong-A ST Details
2.7.2 Dong-A ST Major Business
2.7.3 Dong-A ST Erectile Dysfunction Product and Services
2.7.4 Dong-A ST Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Dong-A ST Recent Developments/Updates
2.8 Petros Pharmaceuticals
2.8.1 Petros Pharmaceuticals Details
2.8.2 Petros Pharmaceuticals Major Business
2.8.3 Petros Pharmaceuticals Erectile Dysfunction Product and Services
2.8.4 Petros Pharmaceuticals Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Petros Pharmaceuticals Recent Developments/Updates
2.9 Seoul Pharma
2.9.1 Seoul Pharma Details
2.9.2 Seoul Pharma Major Business
2.9.3 Seoul Pharma Erectile Dysfunction Product and Services
2.9.4 Seoul Pharma Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Seoul Pharma Recent Developments/Updates
2.10 Yabang Pharmacy
2.10.1 Yabang Pharmacy Details
2.10.2 Yabang Pharmacy Major Business
2.10.3 Yabang Pharmacy Erectile Dysfunction Product and Services
2.10.4 Yabang Pharmacy Erectile Dysfunction Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Yabang Pharmacy Recent Developments/Updates
3 Competitive Environment: Erectile Dysfunction by Manufacturer
3.1 Global Erectile Dysfunction Sales Quantity by Manufacturer (2018-2023)
3.2 Global Erectile Dysfunction Revenue by Manufacturer (2018-2023)
3.3 Global Erectile Dysfunction Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Erectile Dysfunction by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Erectile Dysfunction Manufacturer Market Share in 2022
3.4.2 Top 6 Erectile Dysfunction Manufacturer Market Share in 2022
3.5 Erectile Dysfunction Market: Overall Company Footprint Analysis
3.5.1 Erectile Dysfunction Market: Region Footprint
3.5.2 Erectile Dysfunction Market: Company Product Type Footprint
3.5.3 Erectile Dysfunction Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Erectile Dysfunction Market Size by Region
4.1.1 Global Erectile Dysfunction Sales Quantity by Region (2018-2029)
4.1.2 Global Erectile Dysfunction Consumption Value by Region (2018-2029)
4.1.3 Global Erectile Dysfunction Average Price by Region (2018-2029)
4.2 North America Erectile Dysfunction Consumption Value (2018-2029)
4.3 Europe Erectile Dysfunction Consumption Value (2018-2029)
4.4 Asia-Pacific Erectile Dysfunction Consumption Value (2018-2029)
4.5 South America Erectile Dysfunction Consumption Value (2018-2029)
4.6 Middle East and Africa Erectile Dysfunction Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Erectile Dysfunction Sales Quantity by Type (2018-2029)
5.2 Global Erectile Dysfunction Consumption Value by Type (2018-2029)
5.3 Global Erectile Dysfunction Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Erectile Dysfunction Sales Quantity by Application (2018-2029)
6.2 Global Erectile Dysfunction Consumption Value by Application (2018-2029)
6.3 Global Erectile Dysfunction Average Price by Application (2018-2029)
7 North America
7.1 North America Erectile Dysfunction Sales Quantity by Type (2018-2029)
7.2 North America Erectile Dysfunction Sales Quantity by Application (2018-2029)
7.3 North America Erectile Dysfunction Market Size by Country
7.3.1 North America Erectile Dysfunction Sales Quantity by Country (2018-2029)
7.3.2 North America Erectile Dysfunction Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Erectile Dysfunction Sales Quantity by Type (2018-2029)
8.2 Europe Erectile Dysfunction Sales Quantity by Application (2018-2029)
8.3 Europe Erectile Dysfunction Market Size by Country
8.3.1 Europe Erectile Dysfunction Sales Quantity by Country (2018-2029)
8.3.2 Europe Erectile Dysfunction Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Erectile Dysfunction Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Erectile Dysfunction Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Erectile Dysfunction Market Size by Region
9.3.1 Asia-Pacific Erectile Dysfunction Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Erectile Dysfunction Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Erectile Dysfunction Sales Quantity by Type (2018-2029)
10.2 South America Erectile Dysfunction Sales Quantity by Application (2018-2029)
10.3 South America Erectile Dysfunction Market Size by Country
10.3.1 South America Erectile Dysfunction Sales Quantity by Country (2018-2029)
10.3.2 South America Erectile Dysfunction Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Erectile Dysfunction Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Erectile Dysfunction Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Erectile Dysfunction Market Size by Country
11.3.1 Middle East & Africa Erectile Dysfunction Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Erectile Dysfunction Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Erectile Dysfunction Market Drivers
12.2 Erectile Dysfunction Market Restraints
12.3 Erectile Dysfunction Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Erectile Dysfunction and Key Manufacturers
13.2 Manufacturing Costs Percentage of Erectile Dysfunction
13.3 Erectile Dysfunction Production Process
13.4 Erectile Dysfunction Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Erectile Dysfunction Typical Distributors
14.3 Erectile Dysfunction Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Erectile Dysfunction Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Erectile Dysfunction Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly Major Business
Table 5. Eli Lilly Erectile Dysfunction Product and Services
Table 6. Eli Lilly Erectile Dysfunction Sales Quantity (Million Pill), Average Price (USD/Pill), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Eli Lilly Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Erectile Dysfunction Product and Services
Table 11. Pfizer Erectile Dysfunction Sales Quantity (Million Pill), Average Price (USD/Pill), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Erectile Dysfunction Product and Services
Table 16. Bayer Erectile Dysfunction Sales Quantity (Million Pill), Average Price (USD/Pill), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bayer Recent Developments/Updates
Table 18. BaiYunShan General Factory Basic Information, Manufacturing Base and Competitors
Table 19. BaiYunShan General Factory Major Business
Table 20. BaiYunShan General Factory Erectile Dysfunction Product and Services
Table 21. BaiYunShan General Factory Erectile Dysfunction Sales Quantity (Million Pill), Average Price (USD/Pill), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. BaiYunShan General Factory Recent Developments/Updates
Table 23. S.K. Chemicals Basic Information, Manufacturing Base and Competitors
Table 24. S.K. Chemicals Major Business
Table 25. S.K. Chemicals Erectile Dysfunction Product and Services
Table 26. S.K. Chemicals Erectile Dysfunction Sales Quantity (Million Pill), Average Price (USD/Pill), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. S.K. Chemicals Recent Developments/Updates
Table 28. Teva Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Teva Pharma Major Business
Table 30. Teva Pharma Erectile Dysfunction Product and Services
Table 31. Teva Pharma Erectile Dysfunction Sales Quantity (Million Pill), Average Price (USD/Pill), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Teva Pharma Recent Developments/Updates
Table 33. Dong-A ST Basic Information, Manufacturing Base and Competitors
Table 34. Dong-A ST Major Business
Table 35. Dong-A ST Erectile Dysfunction Product and Services
Table 36. Dong-A ST Erectile Dysfunction Sales Quantity (Million Pill), Average Price (USD/Pill), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Dong-A ST Recent Developments/Updates
Table 38. Petros Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Petros Pharmaceuticals Major Business
Table 40. Petros Pharmaceuticals Erectile Dysfunction Product and Services
Table 41. Petros Pharmaceuticals Erectile Dysfunction Sales Quantity (Million Pill), Average Price (USD/Pill), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Petros Pharmaceuticals Recent Developments/Updates
Table 43. Seoul Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Seoul Pharma Major Business
Table 45. Seoul Pharma Erectile Dysfunction Product and Services
Table 46. Seoul Pharma Erectile Dysfunction Sales Quantity (Million Pill), Average Price (USD/Pill), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Seoul Pharma Recent Developments/Updates
Table 48. Yabang Pharmacy Basic Information, Manufacturing Base and Competitors
Table 49. Yabang Pharmacy Major Business
Table 50. Yabang Pharmacy Erectile Dysfunction Product and Services
Table 51. Yabang Pharmacy Erectile Dysfunction Sales Quantity (Million Pill), Average Price (USD/Pill), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Yabang Pharmacy Recent Developments/Updates
Table 53. Global Erectile Dysfunction Sales Quantity by Manufacturer (2018-2023) & (Million Pill)
Table 54. Global Erectile Dysfunction Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Erectile Dysfunction Average Price by Manufacturer (2018-2023) & (USD/Pill)
Table 56. Market Position of Manufacturers in Erectile Dysfunction, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Erectile Dysfunction Production Site of Key Manufacturer
Table 58. Erectile Dysfunction Market: Company Product Type Footprint
Table 59. Erectile Dysfunction Market: Company Product Application Footprint
Table 60. Erectile Dysfunction New Market Entrants and Barriers to Market Entry
Table 61. Erectile Dysfunction Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Erectile Dysfunction Sales Quantity by Region (2018-2023) & (Million Pill)
Table 63. Global Erectile Dysfunction Sales Quantity by Region (2024-2029) & (Million Pill)
Table 64. Global Erectile Dysfunction Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Erectile Dysfunction Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Erectile Dysfunction Average Price by Region (2018-2023) & (USD/Pill)
Table 67. Global Erectile Dysfunction Average Price by Region (2024-2029) & (USD/Pill)
Table 68. Global Erectile Dysfunction Sales Quantity by Type (2018-2023) & (Million Pill)
Table 69. Global Erectile Dysfunction Sales Quantity by Type (2024-2029) & (Million Pill)
Table 70. Global Erectile Dysfunction Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Erectile Dysfunction Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Erectile Dysfunction Average Price by Type (2018-2023) & (USD/Pill)
Table 73. Global Erectile Dysfunction Average Price by Type (2024-2029) & (USD/Pill)
Table 74. Global Erectile Dysfunction Sales Quantity by Application (2018-2023) & (Million Pill)
Table 75. Global Erectile Dysfunction Sales Quantity by Application (2024-2029) & (Million Pill)
Table 76. Global Erectile Dysfunction Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Erectile Dysfunction Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Erectile Dysfunction Average Price by Application (2018-2023) & (USD/Pill)
Table 79. Global Erectile Dysfunction Average Price by Application (2024-2029) & (USD/Pill)
Table 80. North America Erectile Dysfunction Sales Quantity by Type (2018-2023) & (Million Pill)
Table 81. North America Erectile Dysfunction Sales Quantity by Type (2024-2029) & (Million Pill)
Table 82. North America Erectile Dysfunction Sales Quantity by Application (2018-2023) & (Million Pill)
Table 83. North America Erectile Dysfunction Sales Quantity by Application (2024-2029) & (Million Pill)
Table 84. North America Erectile Dysfunction Sales Quantity by Country (2018-2023) & (Million Pill)
Table 85. North America Erectile Dysfunction Sales Quantity by Country (2024-2029) & (Million Pill)
Table 86. North America Erectile Dysfunction Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Erectile Dysfunction Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Erectile Dysfunction Sales Quantity by Type (2018-2023) & (Million Pill)
Table 89. Europe Erectile Dysfunction Sales Quantity by Type (2024-2029) & (Million Pill)
Table 90. Europe Erectile Dysfunction Sales Quantity by Application (2018-2023) & (Million Pill)
Table 91. Europe Erectile Dysfunction Sales Quantity by Application (2024-2029) & (Million Pill)
Table 92. Europe Erectile Dysfunction Sales Quantity by Country (2018-2023) & (Million Pill)
Table 93. Europe Erectile Dysfunction Sales Quantity by Country (2024-2029) & (Million Pill)
Table 94. Europe Erectile Dysfunction Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Erectile Dysfunction Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Erectile Dysfunction Sales Quantity by Type (2018-2023) & (Million Pill)
Table 97. Asia-Pacific Erectile Dysfunction Sales Quantity by Type (2024-2029) & (Million Pill)
Table 98. Asia-Pacific Erectile Dysfunction Sales Quantity by Application (2018-2023) & (Million Pill)
Table 99. Asia-Pacific Erectile Dysfunction Sales Quantity by Application (2024-2029) & (Million Pill)
Table 100. Asia-Pacific Erectile Dysfunction Sales Quantity by Region (2018-2023) & (Million Pill)
Table 101. Asia-Pacific Erectile Dysfunction Sales Quantity by Region (2024-2029) & (Million Pill)
Table 102. Asia-Pacific Erectile Dysfunction Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Erectile Dysfunction Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Erectile Dysfunction Sales Quantity by Type (2018-2023) & (Million Pill)
Table 105. South America Erectile Dysfunction Sales Quantity by Type (2024-2029) & (Million Pill)
Table 106. South America Erectile Dysfunction Sales Quantity by Application (2018-2023) & (Million Pill)
Table 107. South America Erectile Dysfunction Sales Quantity by Application (2024-2029) & (Million Pill)
Table 108. South America Erectile Dysfunction Sales Quantity by Country (2018-2023) & (Million Pill)
Table 109. South America Erectile Dysfunction Sales Quantity by Country (2024-2029) & (Million Pill)
Table 110. South America Erectile Dysfunction Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Erectile Dysfunction Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Erectile Dysfunction Sales Quantity by Type (2018-2023) & (Million Pill)
Table 113. Middle East & Africa Erectile Dysfunction Sales Quantity by Type (2024-2029) & (Million Pill)
Table 114. Middle East & Africa Erectile Dysfunction Sales Quantity by Application (2018-2023) & (Million Pill)
Table 115. Middle East & Africa Erectile Dysfunction Sales Quantity by Application (2024-2029) & (Million Pill)
Table 116. Middle East & Africa Erectile Dysfunction Sales Quantity by Region (2018-2023) & (Million Pill)
Table 117. Middle East & Africa Erectile Dysfunction Sales Quantity by Region (2024-2029) & (Million Pill)
Table 118. Middle East & Africa Erectile Dysfunction Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Erectile Dysfunction Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Erectile Dysfunction Raw Material
Table 121. Key Manufacturers of Erectile Dysfunction Raw Materials
Table 122. Erectile Dysfunction Typical Distributors
Table 123. Erectile Dysfunction Typical Customers
List of Figures
Figure 1. Erectile Dysfunction Picture
Figure 2. Global Erectile Dysfunction Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Erectile Dysfunction Consumption Value Market Share by Type in 2022
Figure 4. Sildenafil Examples
Figure 5. Tadalafil Examples
Figure 6. Others Examples
Figure 7. Global Erectile Dysfunction Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Erectile Dysfunction Consumption Value Market Share by Application in 2022
Figure 9. Hospital Pharmacies Examples
Figure 10. Private Clinics Examples
Figure 11. Retail Pharmacies Examples
Figure 12. E-Commerce (B2B) Examples
Figure 13. E-Commerce (B2C) Examples
Figure 14. Global Erectile Dysfunction Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Erectile Dysfunction Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Erectile Dysfunction Sales Quantity (2018-2029) & (Million Pill)
Figure 17. Global Erectile Dysfunction Average Price (2018-2029) & (USD/Pill)
Figure 18. Global Erectile Dysfunction Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Erectile Dysfunction Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Erectile Dysfunction by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Erectile Dysfunction Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Erectile Dysfunction Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Erectile Dysfunction Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Erectile Dysfunction Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Erectile Dysfunction Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Erectile Dysfunction Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Erectile Dysfunction Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Erectile Dysfunction Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Erectile Dysfunction Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Erectile Dysfunction Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Erectile Dysfunction Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Erectile Dysfunction Average Price by Type (2018-2029) & (USD/Pill)
Figure 33. Global Erectile Dysfunction Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Erectile Dysfunction Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Erectile Dysfunction Average Price by Application (2018-2029) & (USD/Pill)
Figure 36. North America Erectile Dysfunction Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Erectile Dysfunction Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Erectile Dysfunction Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Erectile Dysfunction Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Erectile Dysfunction Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Erectile Dysfunction Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Erectile Dysfunction Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Erectile Dysfunction Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Erectile Dysfunction Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Erectile Dysfunction Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Erectile Dysfunction Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Erectile Dysfunction Consumption Value Market Share by Region (2018-2029)
Figure 56. China Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Erectile Dysfunction Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Erectile Dysfunction Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Erectile Dysfunction Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Erectile Dysfunction Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Erectile Dysfunction Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Erectile Dysfunction Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Erectile Dysfunction Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Erectile Dysfunction Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Erectile Dysfunction Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Erectile Dysfunction Market Drivers
Figure 77. Erectile Dysfunction Market Restraints
Figure 78. Erectile Dysfunction Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Erectile Dysfunction in 2022
Figure 81. Manufacturing Process Analysis of Erectile Dysfunction
Figure 82. Erectile Dysfunction Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
